Extrait

The purpose of this protocol is to determine if an investigational drug known as LY333531 is effective in treating nerve malfunction in diabetes.

Critère d'inclusion

• Diabetic Neuropathies ,Diabetes Mellitus, Insulin-Dependent ,Diabetes Mellitus, Non-insulin Dependent

Pays

• Canada
• Croatia
• Finland
• India
• Lithuania
• Netherlands
• United Kingdom
• United States

Liens

• nct
• ictrp